Michael Terrence Gibbs - 24 Mar 2023 Form 4/A - Amendment Insider Report for T2 Biosystems, Inc. (TTOO)

Role: General Counsel
Signature: /s/ John Sprague, Attorney-in-fact
Issuer symbol: TTOO
Transactions as of: 24 Mar 2023
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 05 Apr 2023, 14:30:18 UTC
Date Of Original Report: 28 Mar 2023
Previous filing: 09 Mar 2023
Next filing: 06 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TTOO	Common Stock	Options Exercise		+334	+5.1%		6,851	24 Mar 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TTOO	Restricted Stock Units	Options Exercise	$0	-334	-100%	$0.000000^*	0	24 Mar 2023	Common Stock	334		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Form 4, as originally filed, incorrectly reported the amount of shares acquired as a result of the vesting of the Restricted Stock Units as 333.
F2	Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3	On March 24, 2020 the reporting person was granted 1,000 RSU's that vest in three equal annual installments commencing on March 24, 2021